bp(GO:"GO:0007271") association path(MESH:D003071)

View Subject View Object

PubMed:16273023

Among the systems affected in patients with Alzheimer's disease are the cholinergic and glutamatergic neurotransmission systems. These two systems play key roles in cognition and, as a result, contemporary pharmacologic agents used in the treatment of Alzheimer's disease are designed to restore their functioning

Related Edges 5

• bp(GO:"GO:0035249") association path(MESH:D003071)
• path(MESH:D000544) decreases bp(GO:"GO:0007271")
• path(MESH:D000544) decreases bp(GO:"GO:0035249")
• path(MESH:D003071) association bp(GO:"GO:0035249")
• path(MESH:D003071) association bp(GO:"GO:0007271")

Disease Ontology (DO)

Alzheimer's disease

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.

If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.

---